RecruitingRecruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868 · Bristol-Myers Squibb
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment
About this study
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies.
Eligibility criteria
Inclusion Criteria
* Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic triple-negative breast cancer (TNBC) (ER \< 1%, PgR \< 1%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) per American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, based on the most recently analyzed biopsy or other pathology specimen.
* Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
* Participants with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 (eg, pembrolizumab) or an anti-PD-L1 (eg, atezolizumab) due to any one of the following criteria:
i) Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of standard of care (SoC); ii) Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1; iii) Has a severe auto-immune disease or other contraindication, in the opinion of the investigator, for the use of an anti-PD(L)1 drug: iv) Any auto-immune disease that requires current immunosuppression (eg, methotrexate, cyclophosphamide, prednisone \> 10 mg/day).
v) Prior auto-immune AE to peri-adjuvant ICI that required immunosuppression. vi) Current Graves' disease with ophthalmopathy or in need of radioiodine or in use of antithyroid medication.
vii) Current or prior auto-immune diseases per below: A. Moderate to severe rheumatoid arthritis. B. Auto-immune hepatitis or cholangitis. C. Myasthenia gravis. D. Moderate-to-severe or poorly controlled inflammatory bowel disease. E. Multiple sclerosis. F. Lupus with kidney involvement or moderate to severe lupus. G. Auto-immune myocarditis. Note: if participant meets Inclusion Criteria 5b or 5c, unknown PDL1 results per local SOC are acceptable in these specific cases.
* Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
* No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
* Measurable disease by CT or MRI as per RECIST v1.1.
Exclusion Criteria
* Participants with a known germline breast cancer gene (BRCA) 1 or 2 mutation whose best 1L treatment option, in the opinion of the investigator, is a poli-ADP-ribose-polymerase inhibitors (PARPi).
* Untreated symptomatic central nervous system (CNS) metastases. Participants are eligible if CNS metastases have been treated, and participants' neurological signs and symptoms have returned to baseline. In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least 2 weeks prior to randomization. Imaging performed within 28 days of randomization must document radiographic stability of CNS lesions and be performed after completion of any CNS directed therapy.
* Leptomeningeal metastases.
* Participants with history of severe heart disease including, but not limited to, any of the following:
i) History of clinically significant heart disease (eg, cardiomyopathy, congestive heart failure with New York Heart Association functional classification II to IV, pericarditis, or significant pericardial effusion).
ii) Myocardial infarction, uncontrolled angina, or stroke/transient ischemic attack within the past 6 months.
iii) QTc (by Fridericia's formula) prolongation ≥ 450 msec for males and ≥ 470 msec for females, except for right bundle branch block.
iv) Known LVEF \< 50%.
* Prior therapy with iza-bren or any other ADC targeting EGFR and/or HER3 or containing a topoisomerase 1 inhibitor payload.
* Other protocol-defined Inclusion/Exclusion criteria apply.
Study design
Enrollment target: 600 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-09-11
Estimated completion: 2030-05-15
Last updated: 2026-11-19
Interventions
Drug: Iza-brenDrug: Nab-paclitaxelDrug: PaclitaxelDrug: CapecitabineDrug: CarboplatinDrug: Gemcitabine
Primary outcomes
- • Progression-Free Survival (PFS) (Approximately 22 months from first participant randomization in Phase 3)
- • Recommended Phase 3 Dose (RP3D) of BMS-986507 (Approximately 13 months from first participant randomization in Phase 2)
Sponsor
Bristol-Myers Squibb · industry
With: SystImmune Inc.
Contacts & investigators
ContactBMS Clinical Trials Contact Center www.BMSClinicalTrials.com · contact · Clinical.Trials@bms.com · 855-907-3286
ContactFirst line of the email MUST contain NCT # and Site #. · contact
InvestigatorBristol-Myers Squibb · study_director, Bristol-Myers Squibb
All locations (296)
Local Institution - 0303Not Yet Recruiting
Hot Springs, Arkansas, United States
Local Institution - 0307Withdrawn
Cerritos, California, United States
Local Institution - 0308Withdrawn
Cerritos, California, United States
Local Institution - 0309Withdrawn
Cerritos, California, United States
Local Institution - 0328Active Not Recruiting
Cerritos, California, United States
Local Institution - 0311Withdrawn
Long Beach, California, United States
Local Institution - 0290Completed
Los Angeles, California, United States
Local Institution - 0283Completed
Los Angeles, California, United States
Local Institution - 0353Completed
Newport Beach, California, United States
Local Institution - 0358Withdrawn
Stanford, California, United States
Local Institution - 0289Not Yet Recruiting
Aurora, Colorado, United States
Local Institution - 0367Active Not Recruiting
Denver, Colorado, United States
Local Institution - 0304Completed
Newark, Delaware, United States
Local Institution - 0296Withdrawn
Pembroke Pines, Florida, United States
Local Institution - 0294Completed
Atlanta, Georgia, United States
Local Institution - 0357Completed
Atlanta, Georgia, United States
Local Institution - 0278Withdrawn
Chicago, Illinois, United States
Local Institution - 0280Not Yet Recruiting
Chicago, Illinois, United States
Local Institution - 0275Completed
Decatur, Illinois, United States
Local Institution - 0324Withdrawn
O'Fallon, Illinois, United States
Local Institution - 0286Completed
Covington, Louisiana, United States
Local Institution - 1035Withdrawn
Baltimore, Maryland, United States
Local Institution - 0288Completed
Boston, Massachusetts, United States
Local Institution - 0287Active Not Recruiting
Boston, Massachusetts, United States
Local Institution - 0359Completed
Detroit, Michigan, United States
Local Institution - 0313Completed
Maple Grove, Minnesota, United States
Local Institution - 0372Withdrawn
Minneapolis, Minnesota, United States
Local Institution - 0284Completed
Kansas City, Missouri, United States
Local Institution - 0312Withdrawn
New York, New York, United States
Local Institution - 0279Completed
New York, New York, United States
Local Institution - 1037Withdrawn
Syracuse, New York, United States
Local Institution - 0295Completed
Westbury, New York, United States
Local Institution - 0285Completed
White Plains, New York, United States
Local Institution - 0276Completed
Durham, North Carolina, United States
Local Institution - 0316Completed
Eugene, Oregon, United States
Local Institution - 0356Active Not Recruiting
Allentown, Pennsylvania, United States
Local Institution - 0310Completed
Philadelphia, Pennsylvania, United States
Local Institution - 0360Withdrawn
Pittsburgh, Pennsylvania, United States
Local Institution - 0281Completed
Greenville, South Carolina, United States
Local Institution - 0315Completed
Austin, Texas, United States
Local Institution - 0368Completed
El Paso, Texas, United States
Local Institution - 0305Active Not Recruiting
Flower Mound, Texas, United States
Local Institution - 0314Completed
Houston, Texas, United States
Local Institution - 0277Active Not Recruiting
Midlothian, Virginia, United States
Local Institution - 0301Not Yet Recruiting
Roanoke, Virginia, United States
Local Institution - 0302Active Not Recruiting
Winchester, Virginia, United States
Local Institution - 0011Not Yet Recruiting
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Local Institution - 0214Completed
ABB, Buenos Aires F.D., Argentina
Local Institution - 0143Active Not Recruiting
Córdoba, Córdoba Province, Argentina
Local Institution - 0137Active Not Recruiting
Río Cuarto, Córdoba Province, Argentina
Local Institution - 0142Active Not Recruiting
Rosario, Santa Fe Province, Argentina
Local Institution - 0345Completed
Buenos Aires, Argentina
Local Institution - 0012Active Not Recruiting
Buenos Aires, Argentina
Local Institution - 0317Active Not Recruiting
Buenos Aires, Argentina
Local Institution - 0346Not Yet Recruiting
Buenos Aires, Argentina
Local Institution - 0348Completed
Mendoza, Argentina
Local Institution - 0170Active Not Recruiting
Macquarie University, New South Wales, Australia
Local Institution - 0035Active Not Recruiting
Brisbane, Queensland, Australia
Local Institution - 0197Active Not Recruiting
Ballarat Central, Victoria, Australia
Local Institution - 0031Active Not Recruiting
Heidelberg, Victoria, Australia
Local Institution - 0274Active Not Recruiting
Melbourne, Victoria, Australia
Local Institution - 0028Completed
Subiaco, Western Australia, Australia
Local Institution - 0292Active Not Recruiting
Graz, Styria, Austria
Local Institution - 0268Active Not Recruiting
Innsbruck, Tyrol, Austria
Local Institution - 0267Active Not Recruiting
Salzburg, Austria
Local Institution - 0270Active Not Recruiting
Sankt Pölten, Austria
Local Institution - 0269Active Not Recruiting
Vienna, Austria
Local Institution - 0187Withdrawn
Manaus, Amazonas, Brazil
Local Institution - 0147Active Not Recruiting
Fortaleza, Ceará, Brazil
Local Institution - 0157Completed
Vitória, Espírito Santo, Brazil
Local Institution - 1038Withdrawn
Lago Sul, Federal District, Brazil
Local Institution - 0159Completed
Curitiba, Paraná, Brazil
Local Institution - 0199Completed
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0148Active Not Recruiting
Barretos, São Paulo, Brazil
Local Institution - 0164Active Not Recruiting
São José do Rio Preto, São Paulo, Brazil
Local Institution - 0153Active Not Recruiting
Rio de Janeiro, Brazil
Local Institution - 0144Active Not Recruiting
São Paulo, Brazil
Local Institution - 0149Active Not Recruiting
São Paulo, Brazil
BC Cancer KelownaRecruiting
Kelowna, British Columbia, Canada
Local Institution - 0217Withdrawn
Victoria, British Columbia, Canada
The Ottawa Hospital - General CampusRecruiting
Ottawa, Ontario, Canada
Centre Hospitalier de l'Université de MontréalRecruiting
Montreal, Quebec, Canada
McGill University Health CentreRecruiting
Montreal, Quebec, Canada
Centre Intégré de Santé et de Services Sociaux de LanaudièreRecruiting
Saint-Charles-Borromée, Quebec, Canada
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSRecruiting
Sherbrooke, Quebec, Canada
Local Institution - 0138Completed
Santiago, Santiago Metropolitan, Chile
Local Institution - 0021Active Not Recruiting
Santiago, Santiago Metropolitan, Chile
Local Institution - 0017Active Not Recruiting
Santiago, Santiago Metropolitan, Chile
Local Institution - 0018Active Not Recruiting
Santiago, Santiago Metropolitan, Chile
Local Institution - 0016Completed
Viña del Mar, Valparaiso, Chile
Anhui Provincial HospitalRecruiting
Hefei, Anhui, China
The Second Hospital of Anhui Medical UniversityRecruiting
Hefei, Anhui, China
Beijing Cancer HospitalRecruiting
Beijing, Beijing Municipality, China
China-Japan Friendship HospitalRecruiting
Beijing, Beijing Municipality, China
Cancer Hospital Chinese Academy of Medical SciencesRecruiting
Beijing, BEI, China
Fujian Cancer HospitalRecruiting
Fuzhou, Fujian, China
Fujian Medical University Union HospitalRecruiting
Fyzhou, Fujian, China
Local Institution - 1016Withdrawn
Xiamen, Fujian, China
The First Hospital of Lanzhou UniversityRecruiting
Lanzhou, Gansu, China
Guangxi Medical University Affiliated Cancer HospitalRecruiting
Nanning, Guangxi, China
The First Hospital of harbin UniversityRecruiting
Harbin, Harbin, China
Anyang Cancer HospitalRecruiting
Anyang, Henan, China
Henan Cancer HospitalRecruiting
Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
Zhengzhou, Henan, China
Zhongnan Hospital of Wuhan UniversityRecruiting
Wuhan, Hubei, China
Hubei Cancer HospitalRecruiting
Wuhan, Hubei, China
Xiangyang Central HospitalRecruiting
Xiangyang, Hubei, China
Local Institution - 1011Not Yet Recruiting
Changsha, HUN, China
Jiangxi Cancer HospitalRecruiting
Nanchang, Jiangxi, China
Local Institution - 1012Not Yet Recruiting
Changchun, Liaoning, China
Liaoning Cancer HospitalRecruiting
Shenyang, Liaoning, China
Cancer Hospital of Shandong First Medical UniversityRecruiting
Jinan, Shandong, China
The Affiliated Hospital Of Qingdao UniversityRecruiting
Qingdao, Shandong, China
Shanxi Cancer HospitalRecruiting
Taiyuan, Shanxi, China
Sichuan Provincial People'S HospitalRecruiting
Chengdu, Sichuan, China
Tianjin Cancer Hospital Airport HospitalRecruiting
Tianjin, Tianjin Municipality, China
Tianjin Medical University Cancer Institute & HospitalRecruiting
Tianjin, Tianjin Municipality, China
Yunnan Cancer HospitalRecruiting
Kunming, Yunnan, China
Local Institution - 1040Not Yet Recruiting
Hangzhou, Zhejiang, China
The First Affiliated Hospital, Zhejiang University School of MedicineRecruiting
Hangzhou, Zhejiang, China
Sun Yat-sen University Cancer CenterRecruiting
Guangzhou, China
Local Institution - 0195Withdrawn
Medellín, Antioquia, Colombia
Local Institution - 0201Not Yet Recruiting
Rionegro, Antioquia, Colombia
Local Institution - 0194Not Yet Recruiting
Barranquilla, Atlántico, Colombia
Local Institution - 0182Withdrawn
Puerto Colombia, Atlántico, Colombia
Local Institution - 0181Not Yet Recruiting
Montería, COR, Colombia
Local Institution - 0327Not Yet Recruiting
Bogota, Cundinamarca, Colombia
Local Institution - 0183Not Yet Recruiting
Cali, Valle del Cauca Department, Colombia
Local Institution - 0349Not Yet Recruiting
Medellín, Colombia
Local Institution - 0089Active Not Recruiting
Bordeaux, Aquitaine, France
Local Institution - 0090Withdrawn
Lyon, Auvergne-Rhône-Alpes, France
Local Institution - 0272Completed
Dijon, Côte-d'Or, France
Local Institution - 0098Withdrawn
Toulouse, Haute-Garonne, France
Institut Régional du Cancer MontpellierRecruiting
Montpellier, Hérault, France
Local Institution - 0099Completed
Rennes, Ille-et-Vilaine, France
Local Institution - 0092Completed
Saint-Herblain, Loire-Atlantique, France
Local Institution - 0091Withdrawn
Reims, Marne, France
Local Institution - 0097Active Not Recruiting
Villejuif, Paris, France
Institut Paoli-CalmettesRecruiting
Marseille, Provence-Alpes-Côte d'Azur Region, France
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'AuvergneRecruiting
Clermont-Ferrand, Puy-de-Dôme, France
Local Institution - 1033Withdrawn
Poitiers, Vienne, France
Local Institution - 0094Completed
Lille, France
Local Institution - 0088Withdrawn
Paris, France
Local Institution - 0320Active Not Recruiting
Esslingen am Neckar, Baden-Wurttemberg, Germany
Local Institution - 0256Active Not Recruiting
Augsburg, Bavaria, Germany
Local Institution - 0271Active Not Recruiting
München, Bavaria, Germany
Local Institution - 0306Active Not Recruiting
Frankfurt am Main, Hesse, Germany
Local Institution - 0333Active Not Recruiting
Langen, Hesse, Germany
Local Institution - 0257Active Not Recruiting
Hanover, Lower Saxony, Germany
Local Institution - 0293Completed
Düsseldorf, North Rhine-Westphalia, Germany
Local Institution - 0263Active Not Recruiting
Essen, North Rhine-Westphalia, Germany
Local Institution - 0254Not Yet Recruiting
Leipzig, Saxony, Germany
Local Institution - 0255Completed
Lübeck, Schleswig-Holstein, Germany
Local Institution - 0261Active Not Recruiting
Berlin, Germany
Local Institution - 0260Active Not Recruiting
Berlin, Germany
Local Institution - 0259Active Not Recruiting
Bonn, Germany
Local Institution - 0258Active Not Recruiting
Dresden, Germany
Local Institution - 0262Active Not Recruiting
Heidelberg, Germany
Local Institution - 0291Active Not Recruiting
Ulm, Germany
Local Institution - 0043Withdrawn
Athens, Attica, Greece
Local Institution - 0042Active Not Recruiting
Athens, Attikí, Greece
Local Institution - 0038Completed
Athens, Attikí, Greece
Local Institution - 0086Completed
Heraklion, Irakleío, Greece
Local Institution - 0337Withdrawn
Mumbai, Maharashtra, India
Local Institution - 0131Withdrawn
Mumbai, Maharashtra, India
Local Institution - 0134Withdrawn
Nagpur, Maharashtra, India
Local Institution - 0352Withdrawn
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0266Withdrawn
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0206Withdrawn
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0125Withdrawn
Chennai, Tamil Nadu, India
Local Institution - 0130Withdrawn
Hyderabad, Telangana, India
Local Institution - 0133Withdrawn
Varanasi, Uttar Pradesh, India
Local Institution - 0186Not Yet Recruiting
Petah Tikva, Central District, Israel
Local Institution - 0044Active Not Recruiting
Ramat Gan, Central District, Israel
Local Institution - 0047Completed
Jerusalem, Jerusalem, Israel
Local Institution - 0048Active Not Recruiting
Hadera, Northern District, Israel
Local Institution - 0123Active Not Recruiting
Haifa, Northern District, Israel
Local Institution - 0051Active Not Recruiting
Naples, Campania, Italy
Local Institution - 0049Completed
Bologna, Emilia-Romagna, Italy
Local Institution - 0057Active Not Recruiting
Aviano, Friuli Venezia Giulia, Italy
Local Institution - 0054Completed
Genoa, Liguria, Italy
Local Institution - 0053Active Not Recruiting
Pontedera, Pisa, Italy
Local Institution - 0055Completed
Prato, Tuscany, Italy
Local Institution - 0052Active Not Recruiting
Milan, Italy
Local Institution - 0058Completed
Naples, Italy
Local Institution - 0061Completed
Novara, Italy
Local Institution - 0056Completed
Padova, Italy
Local Institution - 0062Active Not Recruiting
Roma, Italy
Local Institution - 0236Withdrawn
Nagoya, Aichi-ken, Japan
Local Institution - 0230Withdrawn
Chiba, Chiba, Japan
Local Institution - 0240Withdrawn
Matsuyama, Ehime, Japan
Local Institution - 0226Withdrawn
Otashi, Gunma, Japan
Local Institution - 0222Withdrawn
Sapporo, Hokkaido, Japan
Local Institution - 0232Withdrawn
Kanazawa, Ishikawa-ken, Japan
Local Institution - 0244Withdrawn
Kagoshima, Kagoshima-ken, Japan
Local Institution - 0234Withdrawn
Isehara, Kanagawa, Japan
Local Institution - 0237Withdrawn
Yokohama, Kanagawa, Japan
Local Institution - 0246Withdrawn
Tsu, Mie-ken, Japan
Local Institution - 0223Withdrawn
Sendai, Miyagi, Japan
Local Institution - 0238Withdrawn
Suita, Osaka, Japan
Local Institution - 0227Withdrawn
Hidaka, Saitama, Japan
Local Institution - 0224Withdrawn
Ina-machi, Saitama, Japan
Local Institution - 0231Withdrawn
Bunkyo-ku, Tokyo, Japan
Local Institution - 0229Withdrawn
Chuo-ku, Tokyo, Japan
Local Institution - 0228Withdrawn
Koto, Tokyo, Japan
Local Institution - 0245Withdrawn
Shinagawa-ku, Tokyo, Japan
Local Institution - 0233Withdrawn
Shinjuku-ku, Tokyo, Japan
Local Institution - 0242Withdrawn
Fukuoka, Japan
Local Institution - 0225Withdrawn
Fukushima, Japan
Local Institution - 0243Withdrawn
Hiroshima, Japan
Local Institution - 0235Withdrawn
Kyoto, Japan
Local Institution - 0241Withdrawn
Okayama, Japan
Local Institution - 0239Withdrawn
Osaka, Japan
CENEIT OncologicosRecruiting
Mexico City, DIF, Mexico
Local Institution - 0264Not Yet Recruiting
Tijuana, Estado de Baja California, Mexico
Local Institution - 0178Not Yet Recruiting
Guadalajara, Jalisco, Mexico
Local Institution - 0329Not Yet Recruiting
Mexico City, Mexico City, Mexico
Local Institution - 0175Not Yet Recruiting
Monterrey, Nuevo León, Mexico
Local Institution - 0176Not Yet Recruiting
Monterrey, Nuevo León, Mexico
Local Institution - 0355Withdrawn
Monterrey, Nuevo León, Mexico
Local Institution - 0173Not Yet Recruiting
Oaxaca City, Oaxaca, Mexico
Local Institution - 0179Not Yet Recruiting
Mérida, Yucatán, Mexico
Scientia Investigacion Clinica S.C.Recruiting
Chihuahua City, Mexico
Local Institution - 0189Active Not Recruiting
Skórzewo, Greater Poland Voivodeship, Poland
Local Institution - 0074Withdrawn
Biała Podlaska, Lublin Voivodeship, Poland
Local Institution - 0072Not Yet Recruiting
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0220Active Not Recruiting
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0076Not Yet Recruiting
Opole, Opole Voivodeship, Poland
Local Institution - 0221Active Not Recruiting
Lodz, Łódź Voivodeship, Poland
Instituto Português de Oncologia de Lisboa Francisco GentilRecruiting
Lisbon, Lisbon District, Portugal
Local Institution - 0106Not Yet Recruiting
Lisbon, Lisbon District, Portugal
Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa MariaRecruiting
Lisbon, Lisbon District, Portugal
Instituto Portugês de Oncologia de Coimbra Francisco GentilRecruiting
Coimbra, Portugal
Hospital da Luz LisboaRecruiting
Lisbon, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil, EPERecruiting
Porto, Portugal
Centro Hospitalar de Sao Joao - Hospital de Sao JoaoRecruiting
Porto, Portugal
Local Institution - 0212Not Yet Recruiting
Bistriţa, Bistrița-Năsăud County, Romania
Local Institution - 0213Completed
Bucharest, Bucharest, Romania
Local Institution - 0079Active Not Recruiting
Florești, Cluj, Romania
Local Institution - 0078Completed
Craiova, Dolj, Romania
Local Institution - 0085Active Not Recruiting
Timișoara, Timiș County, Romania
Local Institution - 0083Active Not Recruiting
Bucharest, Romania
Local Institution - 0077Active Not Recruiting
Cluj-Napoca, Romania
Local Institution - 0211Completed
Dumbrăviţa, Romania
Local Institution - 0081Active Not Recruiting
Iași, Romania
Local Institution - 0080Completed
Iași, Romania
Local Institution - 0084Active Not Recruiting
Ploieşti, Romania
Local Institution - 0351Not Yet Recruiting
East London, Eastern Cape, South Africa
Local Institution - 1034Withdrawn
Cape Town, Western Cape, South Africa
Local Institution - 0342Withdrawn
Johannesburg, South Africa
Local Institution - 0336Withdrawn
Pretoria, South Africa
Local Institution - 0341Withdrawn
Pretoria, South Africa
Local Institution - 0340Withdrawn
Soweto, South Africa
Local Institution - 0066Not Yet Recruiting
Goyang-si, Kyǒnggi-do, South Korea
Local Institution - 0067Not Yet Recruiting
Seongnam, Kyǒnggi-do, South Korea
Local Institution - 0068Not Yet Recruiting
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0063Not Yet Recruiting
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0071Not Yet Recruiting
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0064Not Yet Recruiting
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0065Not Yet Recruiting
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0069Not Yet Recruiting
Daegu, Taegu-Kwangyǒkshi, South Korea
CHUAC-Hospital Teresa HerreraRecruiting
A Coruña, A Coruña [La Coruña], Spain
Hospital General Universitario de ElcheRecruiting
Elche, Alicante, Spain
Hospital Universitari Vall d'HebronRecruiting
Barcelona, Barcelona [Barcelona], Spain
Local Institution - 0172Completed
Hospitalet, Barcelona [Barcelona], Spain
Hospital Clínic de BarcelonaRecruiting
Barcelona, Catalunya [Cataluña], Spain
Hospital Universitario DonostiaRecruiting
Donostia / San Sebastian, Gipuzkoa, Spain
Hospital General Universitario Gregorio MarañonRecruiting
Madrid, Madrid, Comunidad de, Spain
Local Institution - 0108Completed
Madrid, Madrid, Comunidad de, Spain
Hospital Universitario Virgen de la VictoriaRecruiting
Málaga, Málaga, Spain
Hospital Clinico de ValenciaRecruiting
Valencia, Valenciana, Comunitat, Spain
Local Institution - 0107Completed
Madrid, Spain
Hospital Universitario Virgen MacarenaRecruiting
Seville, Spain
Local Institution - 0252Active Not Recruiting
Malmö, Skåne Län [se-12], Sweden
Local Institution - 0026Active Not Recruiting
Stockholm, Stockholms Län [se-01], Sweden
Local Institution - 0025Active Not Recruiting
Uppsala, Uppsala Län [se-03], Sweden
Local Institution - 0024Active Not Recruiting
Örebro, Örebro Län [se-18], Sweden
Local Institution - 0247Active Not Recruiting
Linköping, Östergötlands Län [se-05], Sweden
Local Institution - 0250Active Not Recruiting
Sankt Gallen, Canton of St. Gallen, Switzerland
Local Institution - 0249Active Not Recruiting
Lausanne, Canton of Vaud, Switzerland
Local Institution - 0251Active Not Recruiting
Zurich, Switzerland
Local Institution - 0361Not Yet Recruiting
Adana, Turkey (Türkiye)
Local Institution - 0362Not Yet Recruiting
Ankara, Turkey (Türkiye)
Local Institution - 0364Not Yet Recruiting
Istanbul, Turkey (Türkiye)
Local Institution - 0363Not Yet Recruiting
Istanbul, Turkey (Türkiye)
Local Institution - 0323Withdrawn
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0318Withdrawn
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0322Withdrawn
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0319Withdrawn
Abu Dhabi, United Arab Emirates
Local Institution - 0208Completed
Truro, England, United Kingdom
Local Institution - 0004Active Not Recruiting
London, London, City of, United Kingdom
Local Institution - 0204Withdrawn
London, London, City of, United Kingdom
Local Institution - 0209Completed
London, London, City of, United Kingdom
Local Institution - 0171Withdrawn
Belfast, United Kingdom
Local Institution - 0001Active Not Recruiting
Manchester, United Kingdom
Local Institution - 0006Not Yet Recruiting
Nottingham, United Kingdom